Delphi Panel Consensus
Wir möchten Ihnen hier kurz die "Delphi Dry Eye Treatment Recommondations" vorstellen.
Eine Gruppe internationaler Augenexperten, darunter auch der Deutche Berthold Seitz, M.D. hat im Jahr 2004 diesen Konsens ausgearbeitet.
Die folgende Tabelle stammt von Steven L. Maskin, M.D. und wurde von ihm leicht adaptiert.
| Delphi Panel Consensus for Dry Eye Management | ||
| Severity | Signs & Symptoms | Recommended Treatment |
| L1 |
Mild to moderate symptoms; no signs. Mild to moderate conjunctival signs. |
Patient counseling, preserved tears, environmental management, use of hypoallergenic products, water intake. |
| L2 |
Moderate to severe symptoms. Tear film signs, mild corneal punctate staining, corneal staining, visual signs. | Unpreserved tears, gels, ointments, cyclosporine A, secretagogues, topical steroids, nutritional support (flaxseed oil). |
| L3 |
Severe symptoms. Marked corneal punctate staining, central corneal staining, filamentary keratitis. | Tetracyclines, punctal plugs, autologous serum |
| L4 |
Severe symptoms. Severe corneal staining, erosions, conjunctival scarring. | Systemic anti-inflammatory therapy, oral cyclosporine, moisture goggles, acetylcysteine, punctal cautery, surgery. |
Weiterführende Informationen finden Sie z.B. in "Reversing Dry Eye Syndrome" von Steven L. Maskin.
